Cargando…

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes

The world health organization (WHO) called for coordinated global action in 2018 to eliminate cervical cancer, ensuring that every woman is screened and treated for precancerous lesions (World Health Organization. Cervical cancer: an NCD we can overcome. Geneva, 2018. http://www.who.int/director-gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbas, Mahmoud, de Jonge, Jan, Bettendorf, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592588/ https://www.ncbi.nlm.nih.gov/pubmed/36280748 http://dx.doi.org/10.1038/s41598-022-22438-z

Ejemplares similares

Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study
por: Abbas, Mahmoud, et al.
Publicado: (2023)

Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined significance
por: Abbas, Mahmoud, et al.
Publicado: (2022)

Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes
por: Abbas, Mahmoud, et al.
Publicado: (2022)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age
por: Trama, Jason P, et al.
Publicado: (2022)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
por: Kantathavorn, Nuttavut, et al.
Publicado: (2015)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey
por: Muderris, Tuba, et al.
Publicado: (2019)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology
por: Muresu, Narcisa, et al.
Publicado: (2022)

Cervical Cancer Screening in Low Resource Settings: Cytology versus HPV Triage for VIA Positive Women
por: Mishra, Gauravi A., et al.
Publicado: (2019)

HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data
por: Martins, Toni Ricardo, et al.
Publicado: (2016)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
por: Crawford, Robin, et al.
Publicado: (2011)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
por: Brismar-Wendel, S, et al.
Publicado: (2009)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
por: Ramírez, Arianis Tatiana, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
por: Chua, Brandon, et al.
Publicado: (2023)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
por: Pista, Angela, et al.
Publicado: (2019)

Cost-Effectiveness and Cost-Benefit of Cervical Cancer Screening with Liquid Based Cytology Compared with Conventional Cytology in Germany
por: Armstrong, Stephanie F, et al.
Publicado: (2020)

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
por: Kotaniemi-Talonen, L, et al.
Publicado: (2005)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy
por: Possati-Resende, Júlio César, et al.
Publicado: (2023)

Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
por: Volgareva, Galina, et al.
Publicado: (2004)

A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening
por: Patel, Nirali, et al.
Publicado: (2023)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

Comparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening Test
por: Jeong, Hoiseon, et al.
Publicado: (2017)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

PCR and Genotyping for HPV in Cervical Cancer Patients
por: Prakash, Pradyot, et al.
Publicado: (2016)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
por: Ananworanich, J, et al.
Publicado: (2015)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
por: Flores, Yvonne N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gtm4qbm692jsj57o355hpgi8c6